Liu Y - Search Results

1

MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.

Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L. Zhang X, et al. Among authors: liu y. Int J Biol Macromol. 2019 May 15;129:227-232. doi: 10.1016/j.ijbiomac.2019.01.127. Epub 2019 Jan 24. Int J Biol Macromol. 2019. PMID: 30685303

2

[Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80 g].

Liu CL, Xue DW, Liu YL, Wang P. Liu CL, et al. Zhonghua Nan Ke Xue. 2011 May;17(5):431-4. Zhonghua Nan Ke Xue. 2011. PMID: 21837954 Clinical Trial. Chinese.

3

[Inhibitory effect of cocoomyxa gloeobotrydifomis on benign prostate hyperplasia in aged rats and its action mechanism].

Dong LM, Jin Y, Liu YL, Wang P. Dong LM, et al. Among authors: liu yl. Zhonghua Nan Ke Xue. 2013 Jun;19(6):506-10. Zhonghua Nan Ke Xue. 2013. PMID: 23862227 Chinese.

4

Endoscopic realignment in the management of complete transected ureter.

Liu C, Zhang X, Xue D, Liu Y, Wang P. Liu C, et al. Among authors: liu y. Int Urol Nephrol. 2014 Feb;46(2):335-40. doi: 10.1007/s11255-013-0535-7. Epub 2013 Aug 8. Int Urol Nephrol. 2014. PMID: 23925502

5

Clinical significance and biological roles of TRIM24 in human bladder carcinoma.

Xue D, Zhang X, Zhang X, Liu J, Li N, Liu C, Liu Y, Wang P. Xue D, et al. Among authors: liu j, liu y, liu c. Tumour Biol. 2015 Sep;36(9):6849-55. doi: 10.1007/s13277-015-3393-3. Epub 2015 Apr 7. Tumour Biol. 2015. PMID: 25846736

6

Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast.

Ding H, Li N, He X, Liu B, Dong L, Liu Y. Ding H, et al. Among authors: liu y, liu b. Int Urol Nephrol. 2017 Oct;49(10):1723-1730. doi: 10.1007/s11255-017-1671-2. Epub 2017 Jul 29. Int Urol Nephrol. 2017. PMID: 28756610

7

Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling.

Liu J, Gong X, Zhu X, Xue D, Liu Y, Wang P. Liu J, et al. Among authors: liu y. Oncotarget. 2017 Sep 8;8(43):75272-75283. doi: 10.18632/oncotarget.20775. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088864 Free PMC article.

8

PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.

Dong L, Li Y, Xue D, Liu Y. Dong L, et al. Among authors: liu y. IUBMB Life. 2018 Apr;70(4):291-299. doi: 10.1002/iub.1717. Epub 2018 Mar 8. IUBMB Life. 2018. PMID: 29517839 Free article.

9

LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer.

Dong L, Ding H, Li Y, Xue D, Liu Y. Dong L, et al. Among authors: liu y. Cancer Manag Res. 2018 Aug 20;10:2799-2807. doi: 10.2147/CMAR.S170526. eCollection 2018. Cancer Manag Res. 2018. PMID: 30154672 Free PMC article.

10

TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer.

Dong L, Ding H, Li Y, Xue D, Li Z, Liu Y, Zhang T, Zhou J, Wang P. Dong L, et al. Among authors: liu y. Int J Biol Macromol. 2019 Jan;121:200-206. doi: 10.1016/j.ijbiomac.2018.09.168. Epub 2018 Sep 26. Int J Biol Macromol. 2019. PMID: 30267820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,281 results

Search Page

Filters